The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ji-Hye,Oh

第一单位： Department of Cardiology, School of Medicine, and Institute for Medical Science, Keimyung University, Daegu, Korea.

作者： Ji-Hye,Oh ^[1] ; Jae-Man,Lee ^[1] ; Hee-Jung,Lee ^[1] ; Jongmin,Hwang ^[1] ; Cheol Hyun,Lee ^[1] ; Yun-Kyeong,Cho ^[1] ; Hyoung-Seob,Park ^[1] ; Hyuck-Jun,Yoon ^[1] ; Jin-Wook,Chung ^[1] ; Hyungseop,Kim ^[1] ; Chang-Wook,Nam ^[1] ; Seongwook,Han ^[1] ; Seung-Ho,Hur ^[1] ; Jong-Chan,Youn ^[2] ; In-Cheol,Kim ^[1]

作者单位： Department of Cardiology, School of Medicine, and Institute for Medical Science, Keimyung University, Daegu, Korea. ^[1] Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ^[2]

关键词 Angiotensin receptor-neprilysin inhibitor Clinical event Heart failure with reduced ejection fraction Left ventricular ejection fraction Reverse remodelling Sacubitril/valsartan

主题词血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);心律失常, 心性(Arrhythmias, Cardiac);联苯化合物(Biphenyl Compounds);死亡(Death);心力衰竭(Heart Failure);人类(Humans);回顾性研究(Retrospective Studies);每搏输出量(Stroke Volume);四唑类(Tetrazoles);心室功能障碍, 左(Ventricular Dysfunction, Left);心室功能, 左(Ventricular Function, Left);心室重构(Ventricular Remodeling)

DOI 10.1002/ehf2.13940

PMID 35484930

发布时间 2022-11-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

ESC heart failure

2022年9卷4期

2435-2444页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients.

ESC heart failure

相似文献

ESC heart failure

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients.

ESC heart failure

相似文献

ESC heart failure

相关期刊

检索历史清除